Core Insights - Yuaneng Bio is recognized as a national-level "specialized, refined, and innovative small giant" enterprise and a high-tech company, focusing on the research and breakthroughs in deep low-temperature storage technology [1][2] - The company has applied for over 600 domestic and international patents, with more than 500 granted, including PCT patents in the US, EU, and Japan, and holds over 70 software copyrights [1] - Yuaneng Bio has developed a comprehensive ecosystem for sample management, offering an integrated solution that spans from freezing to transportation and revival [2] Group 1 - The company has successfully overcome the automation challenges of accessing samples at -196℃ ultra-low temperatures, with its P90 series fully automated storage system receiving multiple awards for its performance and innovation [1] - Yuaneng Bio's automated equipment has been successfully implemented in various projects, including those with the China CDC, Zhejiang CDC, and Suzhou CDC [2] - The company aims to create a seamless technology loop with its product line, which includes -196℃ fully automated storage systems, programmable cooling instruments, sample revival instruments, liquid nitrogen transport tanks, AGV robots, and smart library management platforms [2] Group 2 - In 2025, the company's overseas brand Orcella Instruments will launch the Orcella duo 1100S fully automated ultra-low temperature storage system, which is expected to win the "Outstanding New Product Award" from the International Society for Biological and Environmental Repositories (ISBER) [2] - Yuaneng Bio has been selected for the "Belt and Road" medical device export service platform published by the China (Shanghai) Free Trade Pilot Zone [2] - The company has developed a product matrix covering all temperature ranges and scenarios, including BSN, P, AM, IVF, PBM, and BSE series products [2]

Core Viewpoint - Yuaneng Bio has officially launched its Series B financing and is actively preparing for its listing on the Sci-Tech Innovation Board, focusing on the automation of low-temperature storage technology in the biopharmaceutical sector [1][6]. Group 1: Company Overview - Yuaneng Bio has been dedicated to the research and development of advanced automated low-temperature storage equipment for nearly eight years, with an investment of approximately 800 million yuan [3][6]. - The company has applied for over 600 domestic and international patents, with more than 500 granted [1][3]. - The company aims to transform low-temperature storage technology from laboratory applications to industrialization, driven by policy, capital, and entrepreneurial efforts [1][6]. Group 2: Product Development - Yuaneng Bio has developed a series of automated deep low-temperature biological sample storage devices, achieving a breakthrough from 0 to 1 in research and development [3][6]. - The company has introduced a "honeycomb" storage structure that physically isolates each sample to avoid cross-contamination [3][6]. - The product matrix includes various series such as BSN, P, AM, IVF, PBM, and BSE, successfully implemented in multiple projects across health and research institutions [3][4]. Group 3: Market Strategy - The company is currently in the small-batch manufacturing phase, focusing on standardizing and modularizing its products to reduce production costs for future mass manufacturing [4][6]. - Yuaneng Bio is expanding its market presence domestically while also enhancing collaboration with global partners to attract overseas customers [4][6]. - The company has received recognition for its Orcella duo 1100S automated deep low-temperature storage system, winning the "Outstanding New Product Award" at an international event [4]. Group 4: Future Outlook - The company plans to accelerate the application of its technology in various sectors, including hospitals, disease control centers, and biopharmaceutical companies [6]. - There is a significant focus on the future potential of cell storage, with aspirations for it to become a common practice for families [6]. - Yuaneng Bio is set to complete a new smart manufacturing base in Shanghai in 2024, with a total area of nearly 10,000 square meters [6].